Search

everythinglearnresearchcommunity

for

Search:↓

Biologics for severe asthma have known side effects, but some new risks need more study.

Harriet E. Wilson had a challenging career as a spiritualist in Boston, facing competition and possible racism.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Using Lasswell's model can make CSR communication more effective and trusted.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Skin can be cooled quickly and safely during laser treatments to protect it without affecting deeper layers.

Minoxidil and finasteride effectively treat hair loss.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

HPV vaccines are generally safe but need further investigation for rare side effects.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The authors suggest systematically sourcing new product ideas from various internal and external places to improve innovation.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

A new method using visual aids to diagnose hair diseases was effective after brief training.